• MDS Congress 2026 Session 1101 Evaluation Form

  • Therapeutic Plenary Session 1101

    Parkinson's Disease Early and Advanced Treatment

    October 4, 2026

    08:00 - 09:30

  • Learning Objectives:

    1. Know the key pharmacological and non-pharmacological strategies for managing motor symptoms in early Parkinson's disease
    2. Review treatment strategies for advanced Parkinson's disease, including infusion interventions, and multidisciplinary approaches
    3. Evaluate current and emerging technologies, surgical innovations and devices for advanced Parkinson's disease

  • Session Evaluation

  • The session met its learning objectives
  • The content is relevant to my professional and / or scientific interests.
  • The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.
  • The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.
  • The overall session organization was satisfactory and appropriate.
  • I would recommend this session to a colleague.

  • Faculty Assessment

  • Roberto Cilia, Italy

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Hubert Fernandez, USA

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Katsuo Kimura, Japan

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.
  • The following category best describes your current major professional activity (choose one):

  • Should be Empty: